ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03326674
Brief Title: Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA) (CONTESSA)

First Submitted : October 13, 2017
First Submitted that Met QC Criteria : October 25, 2017
First Posted : October 31, 2017

Last Update Submitted that Met QC Criteria : December 6, 2018
Last Update Posted : December 7, 2018 (Estimate)